Stocks with high levels of insider buying the past 3 months and good analyst coverage.

Analysts Target

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
388	HK$380.80	4.9%	-7.5%	HK$475.0b	HK$517.29	25.5	4.9%	3.4%	Diversified Financials
175	HK$18.99	12.6%	11.7%	HK$207.3b	HK$28.90	11.6	16.8%	2.6%	Automobiles
823	HK$37.48	2.7%	-11.8%	HK$97.0b	HK$45.23	0.6	51.3%	6.8%	Real Estate
1093	HK$7.84	12.5%	-3.1%	HK$90.0b	HK$11.61	23.8	14.6%	3.7%	Pharmaceuticals & Biotech
9926	HK$96.50	9.6%	-12.1%	HK$89.9b	HK$171.75	25.2	46.8%	n/a	Pharmaceuticals & Biotech
1177	HK$4.82	9.3%	-18.4%	HK$85.9b	HK$8.59	31.8	17.0%	2.1%	Pharmaceuticals & Biotech
6181	HK$405.60	17.1%	-62.4%	HK$69.3b	HK$865.83	12.8	18.6%	6.8%	Consumer Durables
6862	HK$11.13	4.8%	-23.5%	HK$60.6b	HK$17.64	13.3	9.5%	6.5%	Consumer Services
9863 New	HK$36.88	7.0%	-37.8%	HK$54.3b	HK$66.47	84.4	38.7%	n/a	Automobiles
1364	HK$21.64	2.4%	-23.5%	HK$50.7b	HK$33.58	14.3	14.6%	2.3%	Consumer Services
1530	HK$17.70	4.8%	-28.6%	HK$45.7b	HK$34.69	4.5	-38.2%	1.4%	Pharmaceuticals & Biotech
960	HK$6.31	5.5%	-35.5%	HK$44.1b	HK$10.24	38.0	33.6%	0%	Real Estate Management and Development
3939	HK$9.17	17.9%	21.3%	HK$40.1b	HK$15.74	25.9	46.6%	1.9%	Materials
101	HK$7.18	4.2%	-3.6%	HK$36.7b	HK$10.48	20.7	17.3%	7.2%	Real Estate Management and Development
1828	HK$29.04	2.3%	-23.6%	HK$35.3b	HK$44.75	28.5	28.4%	n/a	Insurance
23	HK$13.05	4.2%	6.3%	HK$33.9b	HK$14.26	0.3	25.9%	4.7%	Banks
2096	HK$11.64	18.2%	8.8%	HK$30.0b	HK$17.79	19.3	18.0%	1.8%	Pharmaceuticals & Biotech
1318	HK$56.65	9.3%	-46.8%	HK$27.0b	HK$104.09	20.0	17.2%	2.0%	Household
1044	HK$22.96	5.6%	-2.5%	HK$26.5b	HK$28.49	9.1	3.3%	7.0%	Household
3800	HK$0.62	-10.1%	-49.2%	HK$21.6b	HK$1.49	1.2	89.6%	0%	Semiconductors
9606	HK$208.00	14.8%	-30.8%	HK$19.3b	HK$433.98	8.8	98.3%	n/a	Pharmaceuticals & Biotech
2419	HK$47.40	15.4%	-51.1%	HK$18.8b	HK$96.93	11.0	51.4%	0%	Food, Beverage & Tobacco
2460	HK$7.58	3.6%	-36.8%	HK$18.2b	HK$10.83	16.0	12.7%	5.2%	Food, Beverage & Tobacco
512	HK$5.15	9.6%	-46.0%	HK$18.1b	HK$11.90	14.5	17.3%	3.3%	Pharmaceuticals & Biotech

High Insider Buying